Skip to main content
. 2022 Sep 13;10(10):e1423–e1442. doi: 10.1016/S2214-109X(22)00330-8

Figure 3.

Figure 3

Map of reported affordability of inhaled medicines in LMICs

(A) Short-acting beta-agonist inhalers. (B) Inhaled corticosteroid inhalers. (C) Inhaled corticosteroid–long-acting beta-agonist combination inhalers. Affordability means a month's treatment costing less than a day's wage of a lowest paid government employee. LMICs=low-income and middle-income countries.